1417 |
[Evolving Genotyping and Platelet Function Test: Personalized Antiplatelet Therapy Possible in Real Practice?] Pros |
Marc S. Sabatine |
May. 12. 11 |
1416 |
PFO Closure: Where We Are Going to after CLOSURE Study? |
Issam D. Moussa |
May. 12. 11 |
1415 |
Left Main PCI: Where We Are? Where We Are Going? |
Seung-Jung Park |
May. 12. 11 |
1414 |
Minimalist Approach: Physiologic Lesion Assessment Should Guide Routine PCI Therapy ! |
Nico Pijls |
May. 12. 11 |
1413 |
Stenosis, Physiology and Medications Are Not Enough: Vulnerable Plaque Must Be Identified |
Ik-Kyung Jang |
May. 12. 11 |
1412 |
Drug-eluting Balloons will Have an Important Role in Coronary and Peripheral Interventional Therapy |
Juan F. Granada |
May. 12. 11 |
1411 |
Will Bioabsorbable Stents Transform PCI in the Future? |
Patrick W. Serruys |
May. 12. 11 |
1410 |
Transcatheter Renal Denervation Therapy(TREND): A Breakthrough for Refractory Hypertension? |
Andrej Schmidt |
May. 12. 11 |
1409 |
Percutaneous LAA Closure: A Future Management Alternative for Stroke Prevention in AF Patients |
Horst Sievert |
May. 12. 11 |
1408 |
Is OCT Ready for ¡°Prime Time¡±: What¡¯s Known and What We Need to Know for Clinical Applications |
Gary S. Mintz |
May. 12. 11 |